March 21, 2025
Texas Medicaid: State-required medication prior authorization updates
Effective May 1, 2025, we’re adding new prior authorization requirements and updating our clinical criteria for certain medications. This applies to UnitedHealthcare Community Plan of Texas CHIP, STAR, STAR Kids and STAR+PLUS plans.
| Clinical criteria guidelines | Medication | Clinical criteria updates |
|---|---|---|
| Monoclonal antibody agents | Tezspire® (tezepelumab-ekko) | Added criteria for Tezspire |
| Ebglyss™ (lebrikizumab-lbkz) | Added criteria for Ebglyss as approved by the Drug Utilization Review Board |
Please use this information to determine if you need to submit a prior authorization request or make note of the clinical criteria before prescribing these medications.
Questions? We're here to help.
Chat with us or visit our support resources.
PCA-1-25-00654-C&S-NN_03182025
